German sportswear brand Puma has issued a caution for 2025 despite achieving sales growth on a currency-adjusted basis and an ...

The German sportswear brand expects growth this year to be in the low- to mid-single digits amid ongoing political and ...

Puma SE (PMMAF) achieves its highest sales ever, but faces hurdles in translating growth into increased profitability.

Due to its Nextlevel cost efficiency program, Puma said it expects to incur one-time costs of up to €75 million in 2025. In ...

Puma Biotechnology (NASDAQ:PBYI – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday.

PUMA anticipates ongoing geopolitical tensions and economic challenges in 2025, especially trade disputes and currency ...

The company looks to have additional interim data from this trial later in 2025. As mentioned on prior earnings calls and in response to investor questions, Puma continues to evaluate several ...